1. Aggressive Differentiated Thyroid Cancer due to EML4e13-ALKe20 Fusion: A Case Presentation and Review of the Literature
    Rodhan Khthir et al, 2021, Case Reports in Endocrinology CrossRef
  2. Anaplastic lymphoma kinase-special immunity and immunotherapy
    Ye Guo et al, 2022, Frontiers in Immunology CrossRef
  3. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib
    Weifeng Liu et al, 2021, Investigational New Drugs CrossRef
  4. Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
    Kamya Sankar et al, 2021, Cancers CrossRef
  5. Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib
    Shubin W. Shahab et al, 2023, Frontiers in Oncology CrossRef
  6. Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis
    Puyuan Xing et al, 2022, Frontiers in Oncology CrossRef
  7. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells
    Elnaz Salmani-Javan et al, 2023, Frontiers in Oncology CrossRef
  8. ALK-mutated thyroid cancer
    R. V. Orlova et al, 2024, Clinical Case in Oncology CrossRef
  9. Cutaneous inflammatory myofibroblastic tumor with CARS‐ALK fusion: Case report and literature review
    Kasey J. McCollum et al, 2022, Journal of Cutaneous Pathology CrossRef
  10. Pediatric Non-Myofibroblastic Primitive Spindle Cell Tumors with ALK Gene Rearrangements and Response to Crizotinib
    Dinesh Rakheja et al, 2022, International Journal of Surgical Pathology CrossRef
  11. ALK-rearranged renal cell carcinoma—different morphological faces of a rare tumor
    Niels J. Rupp et al, 2020, Virchows Archiv CrossRef
  12. Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma
    Kyaw Zwar Myint et al, 2023, Frontiers in Oncology CrossRef
  13. Current status and challenges of immunotherapy in ALK rearranged NSCLC
    Rongbin Qi et al, 2022, Frontiers in Oncology CrossRef
  14. The role of molecular testing in thyroid tumors
    Vera A. Kachko et al, 2020, Problems of Endocrinology CrossRef